mohamad e. allaf, md, shares the most intriguing research presented at asco gu 2017
Published 7 years ago • 181 plays • Length 0:28
Download video MP4
Download video MP3
Similar videos
-
1:20
mohamad e. allaf, md, on non-metastatic renal cell cancer patients and adjuvant therapy
-
0:39
mohamad e. allaf, md, on helping non-metastatic renal cell carcinoma patients with adjuvant therapy
-
0:42
mohamad e. allaf, md, on immunotherapies and renal cell carcinoma treatment algorithms
-
0:36
jeffrey m. holzbeierlein, md, on the impact of his data presented at asco gu 2017
-
0:25
jeffrey m. holzbeierlein, md, highlights the most promising data coming out of asco gu 2017
-
1:20
aref al-kali, md, on the data coming out of asco 2017 regarding flt3 mutant aml patients
-
2:09
the hopkins difference: shaping the future | dr. mohamad allaf (full version)
-
1:26
mohamad e. allaf, md, johns hopkins medicine, department of urology
-
11:30
als patient lisa and her husband discuss her improvements after receiving stem cells treatment
-
1:49:27
a comprehensive functional medicine approach to als with dr. shelena lalji
-
25:23
2021 neuroscience symposium | biology of als: what's going on?
-
1:40:53
dr. jeff rothstein md phd of johns hopkins re personalized medicine in als
-
1:09
the hopkins difference: shaping the future | dr. mohamad allaf (short version)
-
0:34
miriam atkins, md, considers what coa is doing to educate patients on their cancer care
-
4:02
michael soulen, md, tells us about significant data coming out of the tumor board at asco gi 2018
-
6:45
allaf cnn
-
11:25
community partnership in prostate cancer
-
1:04:00
musk agonists as a treatment for als
-
2:21:01
mnd scotland - ask the experts
-
1:16
miles prince, md, on the challenges to recruit and accrue patients to rare-cancer clinical studies
-
1:40:04
2022 outlook for als
-
2:21:01
ask the experts 2018
Clip.africa.com - Privacy-policy